Certain specified neurological disorder aquaporin-4 antibody positive (Q84139): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Desde a descoberta do autoanticorpo neural para aquaporina-4 (AQP4-IgG) como um biomarcador de neuromielite óptica, um espectro mais amplo de doenças neurológicas associadas à soropositividade AQP4-IgG é reconhecido e frequentemente referido como transtorno do espectro NMO (ver distúrbios do espectro NMO [NMOSD ] definição), mas podem ser categorizados sob este título, enfatizando doenças fora dos nervos ópticos e da medula espinal. Isso inclui ataques de náusea / vômito de lesões de área postrema, síndrome de secreção inadequada de hormônio antidiurético (SIADH) ou narcolepsia de lesões hipotalâmicas, síndrome de encefalopatia reversível posterior (PRES) ou encefalomielite disseminada aguda (ADEM) como apresentações de envolvimento cerebral e miosite do envolvimento muscular. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Since discovery of the neural autoantibody to aquaporin-4 (AQP4-IgG) as a biomarker of neuromyelitis optica a wider spectrum of neurological disease associated with AQP4-IgG seropositivity is recognised and often referred to as NMO spectrum disorders (see NMO spectrum disorders [NMOSD] definition), but may be categorized under this heading emphasizing disease outside the optic nerves and spinal cord. This includes nausea/vomiting attacks from area postrema lesions, syndrome of inappropriate anti-diuretic-hormone secretion (SIADH) or narcolepsy from hypothalamic lesions, posterior reversible encephalopathy syndrome (PRES) or acute disseminated encephalomyelitis (ADEM) like presentations from cerebral involvement and myositis from muscle involvement. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/31533652 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_31533652 | |||||||||||||||
| Property / CURIE: CID11:ID_31533652 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_31533652 | |||||||||||||||
| Property / Canary Token: dki-india-ID_31533652 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 09:30, 15 August 2026
Since discovery of the neural autoantibody to aquaporin-4 (AQP4-IgG) as a biomarker of neuromyelitis optica a wider spectrum of neurological disease associated with AQP4-IgG seropositivity is recognised and often referred to as NMO spectrum disorders (see NMO spectrum disorders [NMOSD] definition), but may be categorized under this heading emphasizing disease outside the optic nerves and spinal cord. This includes nausea/vomiting attacks from area postrema lesions, syndrome of inappropriate anti-diuretic-hormone secretion (SIADH) or narcolepsy from hypothalamic lesions, posterior reversible encephalopathy syndrome (PRES) or acute disseminated encephalomyelitis (ADEM) like presentations from cerebral involvement and myositis from muscle involvement.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_31533652 |
||
| English | Certain specified neurological disorder aquaporin-4 antibody positive |
Since discovery of the neural autoantibody to aquaporin-4 (AQP4-IgG) as a biomarker of neuromyelitis optica a wider spectrum of neurological disease associated with AQP4-IgG seropositivity is recognised and often referred to as NMO spectrum disorders (see NMO spectrum disorders [NMOSD] definition), but may be categorized under this heading emphasizing disease outside the optic nerves and spinal cord. This includes nausea/vomiting attacks from area postrema lesions, syndrome of inappropriate anti-diuretic-hormone secretion (SIADH) or narcolepsy from hypothalamic lesions, posterior reversible encephalopathy syndrome (PRES) or acute disseminated encephalomyelitis (ADEM) like presentations from cerebral involvement and myositis from muscle involvement. |
Statements
CID11:ID_31533652
0 references
dki-india-ID_31533652
0 references
Concluído
0 references
13 August 2026
0 references
